Ongoing education and research is critically important to advancing the field of wound care. To help our provider partners stay informed about the latest wound care best practices and developments, we provide a collection of wound care provider resources, including blog posts, articles, studies, guidelines, webinars and white papers.
"My greatest reward of working at Healogics is having the ability to help people…from my collaborative efforts with colleagues and our hospital partners during the development and implementation phase of opening a new Wound Care Center to ultimately helping our patients."
The management of LEAD ulcers mandates a comprehensive approach to treatment. This approach is proven to heal the ulceration and reduce the incidence and level of amputation, thus substantially reducing the cost burden to those individuals with lower extremity arterial disease.
This analysis presents findings from an external third-party analysis of the impact of hyperbaric oxygen therapy (HBO) on diabetic ulcer outcomes, both healing and amputation, using a large sample of Healogics i-heal® data.
This study presents a modified intent-to-treat framework for measuring wound outcomes and measures the consistency of population based outcomes across two distinct settings. In this retrospective observational analysis, we describe the largest to date, cohort of patient wound outcomes derived from 626 hospital based clinics and one academic tertiary care clinic. We present the results of a modified intent-to-treat analysis of wound outcomes as well as demographic and descriptive data.
"Healogics has taught me how to provide wound care at the highest level where I can achieve the best outcomes. I enjoy getting to know my patients and helping to educate them on their wounds and ways to facilitate healing."
"The greatest reward of working at Healogics is the opportunity to provide an avenue of healing to patients that may have suffered for months to years."
"There is always ongoing education and information when it comes to the latest and greatest in advanced wound care. As a Healogics employee, I have access to this information. We never stop learning and this in return provides us the opportunity to grow and be experts in our field."
Radiation induced hemorrhagic cystitis (HC) can occur as early as 3 months after radiation or may not become evident for many years. Significant Grade 3-4 HC occurs in 3 – 8% of post pelvic radiation patients despite advances in administration technique and delivery. Historically, severe hemorrhagic cystitis was associated with a 44% mortality rate despite aggressive urinary diversion and cystectomy. Radiation causes chronic fibrosis, endarteritis and progressive tissue hypoxia of the bladder submucosa and muscular tissue with eventual scarring, mucosal sloughing and symptomatic hemorrhagic cystitis. Radiated tissue is rendered hypoxic, hypocellular, and hypovascular to the point that the tissue is no longer able to heal spontaneously resulting in recurrent symptomatic hematuria.
"During my tenure with Healogics I have had the opportunity to take on new roles with more complex challenges and greater accountability"
"The greatest reward for me is witnessing the literal transformation of a patient who enters our center hopeless, afraid, and helpless to one who is restored to a better quality of life."
